U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C25H46N.Cl
Molecular Weight 396.092
Optical Activity NONE
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CETALKONIUM CHLORIDE

SMILES

[Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1

InChI

InChIKey=SXPWTBGAZSPLHA-UHFFFAOYSA-M
InChI=1S/C25H46N.ClH/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-20-23-26(2,3)24-25-21-18-17-19-22-25;/h17-19,21-22H,4-16,20,23-24H2,1-3H3;1H/q+1;/p-1

HIDE SMILES / InChI

Molecular Formula C25H46N
Molecular Weight 360.6394
Charge 1
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Cetalkonium chloride is a cationic quaternary ammonium surfactant, which is used for the treatment of mouth ulcers and sores (Bonjela trade name). It is also serves as an excipient for the purpose of long-term stabilization of ciclosporin ocular formulation, used in patients with dry eye syndrom (Ikervis trade name). The antibacterial properties of cetalkonium can be explained by its detergent character. Once applied, cetalkonium blocks the survival of biofilm forming bacterias.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
BONJELA

Approved Use

For the relief of pain, discomfort and inflammation caused by common mouth ulcers, cold sores, denture and sore spots, as well as mouth ulcers, and sore spots due to orthodontic devices. To help to fight minor mouth infection and aid healing of sore spots and ulcers due to dentures and orthodontic devices.
Inactive ingredient
IKERVIS

Approved Use

Treatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes.

Launch Date

2015
Primary
BONJELA

Approved Use

For the relief of pain, discomfort and inflammation caused by common mouth ulcers, cold sores, denture and sore spots, as well as mouth ulcers, and sore spots due to orthodontic devices. To help to fight minor mouth infection and aid healing of sore spots and ulcers due to dentures and orthodontic devices.
Doses

Doses

DosePopulationAdverse events​
0.1 % 1 times / day single, topical
Studied dose
Dose: 0.1 %, 1 times / day
Route: topical
Route: single
Dose: 0.1 %, 1 times / day
Sources:
healthy, 28 to 55 years
Health Status: healthy
Age Group: 28 to 55 years
Sex: M+F
Sources:
Other AEs: Contact dermatitis...
Other AEs:
Contact dermatitis (37.5%)
Sources:
AEs

AEs

AESignificanceDosePopulation
Contact dermatitis 37.5%
0.1 % 1 times / day single, topical
Studied dose
Dose: 0.1 %, 1 times / day
Route: topical
Route: single
Dose: 0.1 %, 1 times / day
Sources:
healthy, 28 to 55 years
Health Status: healthy
Age Group: 28 to 55 years
Sex: M+F
Sources:
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Detection of cationic surfactants in oral rinses and a disinfectant formulation using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
2001
Exciplex-type behavior and partition of 3-substituted indole derivatives in reverse micelles made with benzylhexadecyldimethylammonium chloride, water and benzene.
2001 Feb
Occupational allergic contact dermatitis from alkylammonium amidobenzoate.
2001 May-Jun
The trouble with teething--misdiagnosis and misuse of a topical medicament.
2002 May
Sulfentrazone adsorbed on micelle-montmorillonite complexes for slow release in soil.
2003 May 21
Investigation of the effects of wall adsorption of the visualization agent on baseline noise characteristics for indirect UV detection in capillary electrophoresis.
2003 Sep
Influence of enhancers on the absorption and on the pharmacokinetics of cefodizime using in-vitro and in-vivo models.
2004 Apr
Static and dynamic light-scattering studies on micellar solutions of alkyldimethylbenzylammonium chlorides.
2004 Aug 15
The synaptic vesicle proteome: a comparative study in membrane protein identification.
2004 Oct
Immunoisolation of two synaptic vesicle pools from synaptosomes: a proteomics analysis.
2005 Dec
Resonance Rayleigh scattering study of interaction of heparin with some cationic surfactants and their analytical application.
2005 Mar
Enrichment of integral membrane proteins from small amounts of brain tissue.
2006 Aug
Mass spectrometrical identification of brain proteins including highly insoluble and transmembrane proteins.
2006 Aug
Equilibrium studies for the adsorption of acid dye onto modified hectorite.
2006 Aug 25
Analysis of the synaptic vesicle proteome using three gel-based protein separation techniques.
2006 Dec
Condensed film formation of binary mixtures of cetyltrimethylammonium bromide and cetyldimethylbenzylammonium chloride in a wide potential region at the mercury/electrolyte interface.
2006 Dec 1
A new multiphasic buffer system for benzyldimethyl-n-hexadecylammonium chloride polyacrylamide gel electrophoresis of proteins providing efficient stacking.
2006 Feb
Influence of absorption enhancers on the pharmacokinetic properties of non-oral beta-lactam-cefpirom using the rabbit (Chinchilla) in vivo model.
2006 Feb 17
Water remediation by micelle-clay system: case study for tetracycline and sulfonamide antibiotics.
2006 Jul
Release characteristics of anionic drug compounds from liquid crystalline gels. Part II. The effects of ion pairing and buffering on the passive delivery of anionic drugs across non-rate-limiting membranes.
2006 Mar 27
Resonance Rayleigh scattering method for the determination of cationic surfactants with chromium(VI)-iodide system.
2006 May
Dechlorination of beta-methylallyl chloride by electrogenerated [Co(I)(bipyridine)3]+: an electrochemical study in the presence of cationic surfactants.
2006 May 15
Synaptic vesicle proteins under conditions of rest and activation: analysis by 2-D difference gel electrophoresis.
2006 Sep
Visual determination of nitrite and nitrate in waters by color band formation method.
2006 Sep
Comparative study of the photophysical behavior of fisetin in homogeneous media and in anionic and cationic reverse micelles media.
2007 May-Jun
Evaluation of two proteomics technologies used to screen the membrane proteomes of wild-type Corynebacterium glutamicum and an L-lysine-producing strain.
2007 Oct
Two-dimensional separation of membrane proteins by 16-BAC-SDS-PAGE.
2009
16-BAC/SDS-PAGE analysis of membrane proteins of yeast mitochondria purified by free flow electrophoresis.
2009
Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: an in vivo toxicity assay.
2009 Aug 25
Characterization of multifunctional reverse micelles' interfaces using hemicyanines as molecular probes. II: Effect of the surfactant.
2009 May 14
Modulation of excited-state proton-transfer reactions of 7-hydroxy-4-methylcoumarin in ionic and nonionic reverse micelles.
2009 May 14
On the formation of new reverse micelles: a comparative study of benzene/surfactants/ionic liquids systems using UV-visible absorption spectroscopy and dynamic light scattering.
2009 Sep 15
Sorption of quaternary ammonium compounds to municipal sludge.
2010 Apr
Highlights on the capacities of "Gel-based" proteomics.
2010 Apr 28
Cationic reverse micelles create water with super hydrogen-bond-donor capacity for enzymatic catalysis: hydrolysis of 2-naphthyl acetate by alpha-chymotrypsin.
2010 Aug 2
Adsorptive removal of cationic surfactants from aqueous solutions onto high-area activated carbon cloth monitored by in situ UV spectroscopy.
2010 Feb 15
[Optimization of benzalkonium chloride concentration in 0.0015% tafluprost ophthalmic solution from the points of ocular surface safety and preservative efficacy].
2010 Jun
Ammonium detection by formation of colored zebra-bands in a detecting tube.
2010 Jun 15
Synthesis, self-aggregation and biological properties of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride.
2013 Aug
Patents

Sample Use Guides

Massage one centimetre of the topical formulation (Bonjela) onto the affected area (mouth ulcers and sores) and leave at least 30 min in case of denture sores. In dry eye disease, the recommended dose is one drop of the ocular formulation (Ikervis) once daily to be applied to the affected eye(s) at bedtime.
Route of Administration: Other
Corneal human cells were treated with 0.005% cetalkonium chloride cationic oil-inwater nanoemulsion for 30 min. The emulsion was able to increase the pace of healing, as measured by the reduction of the size of the scraped area.
Substance Class Chemical
Created
by admin
on Wed Apr 02 08:32:14 GMT 2025
Edited
by admin
on Wed Apr 02 08:32:14 GMT 2025
Record UNII
85474O1N9D
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CETALKONIUM CHLORIDE
INCI   INN   MART.   MI   USAN   VANDF   WHO-DD  
USAN   INCI   INN  
Official Name English
cetalkonium chloride [INN]
Preferred Name English
ZETTYN
Brand Name English
CDBAC
Common Name English
CETALKONIUM CHLORIDE [VANDF]
Common Name English
CETYL ZEPHIRAN
Common Name English
ACQUAT CDAC
Brand Name English
BENZENEMETHANAMINIUM, N-HEXADECYL, N,N-DIMETHYL-, CHLORIDE
Common Name English
BANICOL
Brand Name English
N-HEXADECYL-N,N-DIMETHYLBENZENEMETHANAMINIUM CHLORIDE
Systematic Name English
CETALKONIUM CHLORIDE [USAN]
Common Name English
Benzylhexadecyldimethylammonium chloride
Systematic Name English
AMMONIUM, BENZYLHEXADECYLDIMETHYL-, CHLORIDE
Systematic Name English
Cetalkonium chloride [WHO-DD]
Common Name English
CETALKONIUM CHLORIDE [MART.]
Common Name English
CETALKONIUM CHLORIDE [MI]
Common Name English
CETYLBENZYLDIMETHYLAMMONIUM CHLORIDE
Systematic Name English
NSC-32942
Code English
Classification Tree Code System Code
EPA PESTICIDE CODE 69108
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
NCI_THESAURUS C28394
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
Code System Code Type Description
SMS_ID
100000082068
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
PRIMARY
NSC
32942
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
PRIMARY
PUBCHEM
31202
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
PRIMARY
WIKIPEDIA
Cetalkonium chloride
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
PRIMARY
DRUG CENTRAL
3078
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
PRIMARY
CAS
122-18-9
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
PRIMARY
MERCK INDEX
m3286
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
PRIMARY Merck Index
EPA CompTox
DTXSID3041665
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
PRIMARY
NCI_THESAURUS
C77034
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
PRIMARY
DAILYMED
85474O1N9D
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
PRIMARY
EVMPD
SUB07445MIG
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
PRIMARY
ECHA (EC/EINECS)
204-526-3
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
PRIMARY
MESH
C012817
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
PRIMARY
DRUG BANK
DBSALT001776
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
PRIMARY
FDA UNII
85474O1N9D
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
PRIMARY
ChEMBL
CHEMBL1624075
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
PRIMARY
INN
1843
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
PRIMARY
RXCUI
47907
Created by admin on Wed Apr 02 08:32:14 GMT 2025 , Edited by admin on Wed Apr 02 08:32:14 GMT 2025
PRIMARY RxNorm
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY